Install
Ajanta Pharma to hold 47th annual general meeting on July 16 Indian Pharma Post Get the latest News & Research on Pharma industry, Viewpoints, Events, Videos, statistics, indianpharmapost.com
- 188articles · 30d
- 7+ hour agolatest article
- Aug 14, 2026earliest in window
- 89%with images
- 245avg words
- Medical 138
- Health & Wellness 101
- Economy, Business & Finance 81
- Health 74
- Business & Industrial 65
- Finance & Business 33
- Science & Technology 21
- News 15
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Neurizon appoints Dr. Chris Bremer as CEO
4+ day, 57+ min ago (277+ words) Neurizon Therapeutics has appointed Dr. Chris Bremer as Chief Executive Officer, effective October 1, 2026 while the Australian biotechnology company advances its lead ALS drug candidate NUZ-001. Dr. Bremer will initially serve as CEO and will not join the board of Neurizon…...
FDA moves to boost estradiol patch supply as demand surges
4+ day, 19+ hour ago (65+ words) Over the past year, the supply of FDA-approved estradiol transdermal patches has nearly doubled FDA moves to boost estradiol patch supply as demand surges Superluminal Medicines raises $60 million to push obesity drug into clinic Novartis’ pelacarsen trial fails to cut…...
Biocon inks 10-year deal to supply breast cancer therapy to Brazil
4+ day, 19+ hour ago (256+ words) Biocon Limited has signed a landmark partnership agreement with Bahiafarma and Bionovis for Pertuzumab in Brazil. This collaboration marks a significant step forward in scaling the production and commercialization of this HER2-positive breast cancer therapy under the country's Productive Development…...
Novartis India enters exclusive distribution deal with NHPL for retina portfolio
4+ day, 19+ hour ago (167+ words) Novartis India Limited has acquired the exclusive rights to promote and distribute NHPL's retina portfolio across India Novartis India Limited has announced the signing of an exclusive promotion and distribution agreement with Novartis Healthcare Private Limited (NHPL) on September 8, 2026. This…...
Novartis’ pelacarsen trial fails to cut cardiovascular risk
4+ day, 21+ hour ago (54+ words) The pivotal cardiovascular outcomes trial did not meet its primary endpoint FDA moves to boost estradiol patch supply as demand surges Superluminal Medicines raises $60 million to push obesity drug into clinic Novartis’ pelacarsen trial fails to cut cardiovascular risk Indian…...
Superluminal Medicines raises $60 million to push obesity drug into clinic
5+ day, 2+ hour ago (62+ words) Indian Pharma Post Superluminal Medicines raises $60 million to push obesity drug into clinic Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The complexity of compliance The…...
Roche Pharma India names five winners of third edition of LEAP Oncology programme
5+ day, 17+ hour ago (442+ words) Roche Pharma India has announced the winners of the third edition of its Leading Engagements to Advance Patient Care (LEAP) programme, recognising five oncology students for developing innovative solutions to challenges in cancer care. The third edition of LEAP invited…...
Sanofi signs three-year partnership with Tricog to scale AI-powered cardiac diagnostics
5+ day, 18+ hour ago (374+ words) Under the proposed three-year collaboration, Sanofi will provide Tricog Health with mentorship, market access support and potential financial investment Prateek Golecha, Chief Growth Officer, Tricog Health (L) with Deepak Arora, Managing Director, Sanofi India (R) Sanofi Healthcare India Pvt. Ltd. has signed…...
AstraZeneca breast cancer drug wins US approval after trial cuts progression risk by 56%
6+ day, 18+ min ago (64+ words) The US Food and Drug Administration’s accelerated approval is based on results from the Phase III SERENA-6 trial Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership…...
Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial
6+ day, 21+ hour ago (68+ words) Indian Pharma Post Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The…...